Absci (NasdaqGS:ABSI) FY Conference September 09, 2025 09:30 AM ET Company ParticipantsAlex Khan - VP, Finance and Investor RelationsAmaro Taylor-Weiner - Chief AI OfficerAmaro Taylor-WeinerAntibody therapeutics that uses an integrated wet lab validation and allowing for rapid generation of antibody therapeutics that are in clinical trials at this point. The company aims to generate target hard-to-drug targets as well as therapies to them with their first clinical candidate, ABS-101, generating data in the ...